*
Corresponding authors
a
Department of Chemistry, South Kensington Campus, Imperial College, London SW7 2AZ, UK
E-mail:
a.c.spivey@imperial.ac.uk
Tel: +44 (0)20 75945841
b
Department of Chemistry, University of Sheffield, Brook Hill, Sheffield S3 7HF, UK
c
AstraZeneca Process Research and Development, Charter Way, Silk Road Business Park, Macclesfield, Cheshire, UK
d
AstraZeneca, Alderley Park, Macclesfield, Cheshire, UK
e
Lead Generation, PRBC-L.y, F. Hoffmann-La Roche, Basel, Switzerland
f
AstraZeneca R and D, Charnwood, Department of Medicinal Chemistry, Bakewell Road, Loughborough, Leics, UK
g
Pharmorphix® Solid State Services, Member of the Sigma-Aldrich Group, 250 Cambridge Science Park, Milton Road, Cambridge, UK